Wall Street Journal -- A Food and Drug Administration official said the agency is finalizing plans to include language warning about suicidal behavior on labels of 11 epilepsy drugs. Sales of the affected drugs, widely used for nonepilepsy problems such as chronic pain, topped $8 billion last year.
